| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/16/2010 | CA2409613C Methods and compositions for treating hepatitis c virus |
| 11/16/2010 | CA2407316C Pet food composition for reducing inflammatory response in cats |
| 11/16/2010 | CA2405479C Method of inhibiting the expression of inflammatory cytokines and chemokines |
| 11/16/2010 | CA2402278C Diabetic nutritionals |
| 11/16/2010 | CA2398901C Methods and compositions for treating conditions of the eye |
| 11/16/2010 | CA2396824C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 11/16/2010 | CA2389165C Substituted indoles for modulating nfkb activity |
| 11/16/2010 | CA2383146C Therapeutic agent for neuropathic pain and neuropathic pain animal model |
| 11/16/2010 | CA2367240C Treatment of accidental extravasation of anthracyclines |
| 11/16/2010 | CA2337361C Targeted site specific drug delivery compositions and method of use |
| 11/16/2010 | CA2330659C Using ngali nut oil to treat/relieve manifestations of arthritis and other similar conditions |
| 11/16/2010 | CA2261334C Bovine polynucleotide vaccine for the intradermal route |
| 11/16/2010 | CA2240339C [3'-desoxy-3'-oxo-mebmt]1-[val]2-ciclosporin-containing emulsion pharmaceutical composition |
| 11/16/2010 | CA2237159C Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates |
| 11/16/2010 | CA2228731C Physically active antimicrobial gel for cosmetic products |
| 11/16/2010 | CA2212047C Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders |
| 11/16/2010 | CA2185123C Steroid derivatives, pharmaceutical compositions containing them, and their pharmaceutical uses |
| 11/15/2010 | CA2666063A1 Compositions suitable for the topical treatment of fungal infections of the skin and nails |
| 11/11/2010 | WO2010129964A1 Drug targets for prevention of arrhythmia in heart disease |
| 11/11/2010 | WO2010129962A2 Combination treatment of hydroxypyridonate actinide/lanthanide decorporation agents |
| 11/11/2010 | WO2010129950A1 Micro-rna that regulates cardiac remodeling |
| 11/11/2010 | WO2010129918A1 Triptolide prodrugs |
| 11/11/2010 | WO2010129861A2 Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family |
| 11/11/2010 | WO2010129858A1 Compounds and compositions comprising cdk inhibitors and methods for the treatment of cancer |
| 11/11/2010 | WO2010129851A1 Methods of analyzing peptide mixtures |
| 11/11/2010 | WO2010129845A1 Methods of preventing ischemic injury using peripheral nociceptive stimulation |
| 11/11/2010 | WO2010129843A1 Dihydronaphthyridinyl and related compounds for use in treating ophthalmological disorders |
| 11/11/2010 | WO2010129839A1 Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans |
| 11/11/2010 | WO2010129816A2 Heterocyclic compounds and uses thereof |
| 11/11/2010 | WO2010129802A1 Inhibitors of jak |
| 11/11/2010 | WO2010129799A2 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
| 11/11/2010 | WO2010129795A1 Oral care method and kit |
| 11/11/2010 | WO2010129791A1 Rna targeting in alpha-synucleinopathies |
| 11/11/2010 | WO2010129788A2 Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders |
| 11/11/2010 | WO2010129757A1 Solid formulations of prostacyclin analogs |
| 11/11/2010 | WO2010129746A2 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp |
| 11/11/2010 | WO2010129740A1 Use of osi-906 for treating adrenocortical carcinoma |
| 11/11/2010 | WO2010129738A1 Method of treating thrombocytopenia |
| 11/11/2010 | WO2010129729A1 Substituted spirocyclic amines useful as antidiabetic compounds |
| 11/11/2010 | WO2010129712A1 15-pgdh in colon cancer |
| 11/11/2010 | WO2010129709A1 Lipid compositions |
| 11/11/2010 | WO2010129708A2 Methods and compositions related to the regulation of goblet cell differentiation, mucus production and mucus secretion |
| 11/11/2010 | WO2010129707A1 Etanercept in combination with glucocorticoids for use in treating psoriasis |
| 11/11/2010 | WO2010129689A1 Milnacipran formulations |
| 11/11/2010 | WO2010129687A1 Methods of delivering oligonucleotides to immune cells |
| 11/11/2010 | WO2010129681A1 Methods for treating autophagy-related disorders |
| 11/11/2010 | WO2010129670A2 Method for modulating angiogenesis using fibromodulin |
| 11/11/2010 | WO2010129668A1 Pyrazolopyridines |
| 11/11/2010 | WO2010129665A2 Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis |
| 11/11/2010 | WO2010129636A2 Lenalidomide polymorph |
| 11/11/2010 | WO2010129620A1 Imidazo [ 1, 2 -a] pyridin-2 -yl-phenyl derivatives to be used in cancer treatment |
| 11/11/2010 | WO2010129596A1 Pmk2 modulators for use in the treatment of cancer |
| 11/11/2010 | WO2010129570A1 Solid forms of sulfonamides and amino acids |
| 11/11/2010 | WO2010129567A1 Pyrrolo [2, 3. b] pyridines which inhibit raf protein kinase |
| 11/11/2010 | WO2010129553A1 S1p3 receptor inhibitors for treating conditions of the eye |
| 11/11/2010 | WO2010129524A2 Plant medicinal compounds |
| 11/11/2010 | WO2010129515A1 Modulation of the tgf-beta and pi3k/akt pathways in the diagnosis and treatment of squamous cell carcinoma |
| 11/11/2010 | WO2010129509A1 Vinyl indazolyl compounds |
| 11/11/2010 | WO2010129500A2 Nematocidal sulfonamides |
| 11/11/2010 | WO2010129497A1 Pesticidal compositions |
| 11/11/2010 | WO2010129486A1 Methods and compositions for treating ophthalmic conditions |
| 11/11/2010 | WO2010129467A1 Compounds and methods for inhibition of renin, and indications therefor |
| 11/11/2010 | WO2010129445A2 Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound |
| 11/11/2010 | WO2010129406A2 Methods of promoting muscle growth |
| 11/11/2010 | WO2010129379A1 Inhibitors of the renal outer medullary potassium channel |
| 11/11/2010 | WO2010129340A2 Novel photosensitizer formulations for oral administration |
| 11/11/2010 | WO2010129337A2 New oral formulations for tetrapyrrole derivatives |
| 11/11/2010 | WO2010129326A1 Pyrrolidine-derived beta 3 adrenergic receptor agonists |
| 11/11/2010 | WO2010129321A2 Topical compositions comprising an alkoxylated diphenylacrylate compound and an aryl carboxylic ester |
| 11/11/2010 | WO2010129318A2 Topical compositions comprising an alkoxylated diphenylacrylate compound and an organic nonionic emulsifier |
| 11/11/2010 | WO2010129313A2 Cosmetic compositions comprising cyanodiphenylacrylates |
| 11/11/2010 | WO2010129294A2 Small molecules supporting pluripotent cell growth and methods thereof |
| 11/11/2010 | WO2010129276A2 PYRO-GLUTAMATE Aβ TARGETING AGENTS |
| 11/11/2010 | WO2010129273A2 Butaclamol for the treatment of amyotrophic lateral sclerosis |
| 11/11/2010 | WO2010129242A2 Treatment of osteoarthritis pain |
| 11/11/2010 | WO2010129233A2 Methods of treating bacterial infections using oritavancin |
| 11/11/2010 | WO2010129145A2 Methods and compositions for treating dry eye |
| 11/11/2010 | WO2010129138A2 Phosphorylated and phosphonated pyrone analogs for therapeutic treatment |
| 11/11/2010 | WO2010129057A2 Tetracycline compounds |
| 11/11/2010 | WO2010129055A1 8-aza tetracycline compounds |
| 11/11/2010 | WO2010129053A2 Egfr inhibitors and methods of treating disorders |
| 11/11/2010 | WO2010129049A1 Benzofuran-4,5-diones as selective peptide deformylase inhibitors |
| 11/11/2010 | WO2010129048A2 Therapeutic compounds |
| 11/11/2010 | WO2010129036A1 Use of pde7 inhibitors for the treatment of movement disorders |
| 11/11/2010 | WO2010129031A1 Gallium complexes with polyalcohols and methods of use |
| 11/11/2010 | WO2010129021A1 Gene therapy for neurodegenerative disorders |
| 11/11/2010 | WO2010128995A1 Phenoxymethyl heterocyclic compounds |
| 11/11/2010 | WO2010128977A1 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine |
| 11/11/2010 | WO2010128949A1 A nutraceutical composition |
| 11/11/2010 | WO2010128889A1 Pharmaceutical composition containing arbidol in the form of phospholipid nanoparticles |
| 11/11/2010 | WO2010128873A1 Combination of an opioid analgesic and an n-type calcium channel blocker for treating chronic pain |
| 11/11/2010 | WO2010128807A2 Pharmaceutical composition for preventing or treating neuronal damage and neurological diseases |
| 11/11/2010 | WO2010128793A2 Fat soluble vitamin and a derivative thereof induced by novel cationic chitosan, a method of producing same and drug delivery system containing same |
| 11/11/2010 | WO2010128788A2 Anti-obesity external dermal agent compositions containing capsaicin or capsaicin-like compounds as active ingredients |
| 11/11/2010 | WO2010128755A2 Composition for preventing or treating hair loss containing threonate as an active ingredient |
| 11/11/2010 | WO2010128717A1 Drug suitability assessment method for prevention or treatment of anxiety disorders using cholinergic type ii theta rhythm |
| 11/11/2010 | WO2010128696A1 Composition for preventing and treating anxiety disorder, containing cholinergic enhancer |
| 11/11/2010 | WO2010128685A1 Alpha helix mimetics and methods relating thereto |
| 11/11/2010 | WO2010128663A1 Interleukin-2 production inhibitor |
| 11/11/2010 | WO2010128659A1 Diamino heterocyclic carboxamide compound |